Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy

Exclusion Criteria

• •Subjects less than 6 years or older than 16 years old
• •AED not stable for at least one month and/or a change in AED is expected in the three months following inclusion.
• •Diagnosis of ADHD hyperactivity type exclusive according to DSM V criteria.
• •Mental retardation defined by a score \< 70 on the verbal comprehension and perceptual reasoning Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV), performed within 18 months prior to inclusion or at V1.
• •Diagnosis of a psychiatric comorbidity other than ADHD according to the DSM V criteria, including: pervasive developmental disorders including autism disorders; bipolar disordersand psychotic disorders.
• •Children suffering from diabetes, any type.
• •Use of psychoactive drugs in ADHD within the previous month: Methylphenidate, Amphetamine, Atomoxetine, Modafinil and Antidepressants whatever the class.
• •Use of dietary supplementation, other than vitamins, within the last 3 months.
• •Use of ketogenic diet within the last 3 months.
• •Allergy to fish or other sea products.
• •Soy allergy.
• •Absence of coverage by social security.